Searchable abstracts of presentations at key conferences in endocrinology

ea0026p701 | Diabetes complications | ECE2011

Receptor activator of nuclear factor kappa β ligand and osteoprotegerin levels in the patients with diabetic nephropathy

Kuzuguden Cigdem , Guldiken Sibel , Ustundag Sedat , Ozgen Zeren , Demir Muzaffer

Aim: The aim of this study was to investigate the relationship between the clinical and laboratory findings of metabolic bone disease regarding the levels of osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa B ligand (RANKL) in the patients with diabetic nephropathy.Material and method: This study includes 61 type 2 diabetic patients and age-, sex-matched 20 healthy subjects. Diabetic patients were divided into three groups accordi...

ea0032p446 | Diabetes | ECE2013

Comparison of Irbesartan and combination with Nigella sativa oil in experimental diabetic nephropathy

Peynirci Hande , Sen Saniye , Kanter Mehmet , Ustundag Sedat , Aktas Cevat , Asker Semra

Introduction: Diabetic nephropathy is the leading cause of chronic renal failure worldwide. Related to the increased glucose and its metabolites, activation of renin–angiotensin–aldosterone system, and increased oxidative stress are important in renal deterioration. The studies indicate that suppression of renin–angiotensin–aldosterone system slow down diabetic nephropathy; Nigella sativa decreases blood glucose and oxidative stress. Were viewed th...